DCM
IMA

DAFNA Capital Management’s ImageneBio Inc IMA Stock Holding History

DAFNA Capital Management’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-9,411
Closed -$390K – 76
2023
Q1 		$390K Sell
9,411
-799
-8% -$36.7K 0.12% 64
2022
Q4 		$326K Hold
10,210
– – 0.09% 66
2022
Q3 		$435K Buy
+10,210
New +$590K 0.12% 74

Other funds holding IMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DAFNA Capital Management's IMA Position: Q2 2023 in Review

DAFNA Capital Management sold out of ImageneBio Inc (IMA) in Q2 2023, closing a stake of 9,411 shares — an estimated $390K sold.

DAFNA Capital Management first reported a position in IMA in Q3 2022 and held it in 3 quarters. The position peaked at $435K in Q3 2022. 52 funds tracked by Wall St. Rank hold IMA as of Q2 2023.

  • DAFNA Capital Management reported no remaining ImageneBio Inc position as of Q2 2023 after selling out during the quarter.
  • DAFNA Capital Management sold 9,411 ImageneBio Inc shares in Q2 2023, an estimated $390K.
  • DAFNA Capital Management first reported a position in ImageneBio Inc in Q3 2022 and held it in 3 quarters.
  • DAFNA Capital Management's ImageneBio Inc position peaked at $435K in Q3 2022.
  • 52 funds tracked by Wall St. Rank held ImageneBio Inc as of Q2 2023.

Based on DAFNA Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.